Submission Deadline | March 25, 2024 |
Notification of Acceptance | May 1, 2024 |
Final Version Due | May 12, 2024 |
Conference | July 19-21, 2024 |
The International Symposium on Bioinformatics Research and Applications (ISBRA) provides a forum for the exchange of ideas and results among researchers, developers, and practitioners working on all aspects of bioinformatics and computational biology and their applications. Submissions presenting original research are solicited in all areas of bioinformatics and computational biology, including the development of experimental or commercial systems. Topics of interest include but are not limited to
Biomarker discovery | High-performance bio-computing |
Biomedical databases and data integration | Metagenomics |
Biomedical text mining and ortologies | Molecular evolution |
Biomolecular imaging | Molecular modelling and simulation |
Comparative genomics | Next-generation sequencing data analysis |
Computational genetic epidemiology | Pattern discovery and classification |
Computational proteomics | Population genetics |
Data mining and visualization | Software tools and applications |
Gene expression analysis | Structural biology |
Genome analysis | AI and machine learning methods in Bioinformatics and Medical Information |
Systems biology | Big Data Analytics in Biology and Medicine |
Please submit extended abstracts (up to 12 pages in Springer LNCS format) via the online submission system (https://easychair.org/conferences/?conf=isbra2024) . Submission implies willingness of at least one author to register and present at the symposium. The authors should choose one of the following tracks:
Track 1: Submit up to 12 pages in LNCS format for (i) publication of the extended abstract in the Springer LNBI Proceedings and (ii) invitation to submit a 30%-50%-extend version to ISBRA’24 special issues. The pending approval journals are:
Track 2: Submit up to 12 pages in LNCS format for (i) presentation at the conference and (ii) invitation to submit a full-length paper to ISBRA’24 special issues. The pending approval journals are: